Salong Debbarma
Publishes 1 feed
Clinical Trials Arena
Hard data and deep insights on clinical trials strategy & operations
17 posts · contributor
Lately
Chemo-free regimen touts breast cancer win amid targeted therapy shift
AstraZeneca trips in PD-1 bispecific market after Phase III NSCLC failure
Study finds metabolic biomarker signature to assist with early HNSCC detection
Enrolment opens for Adaptin Bio’s Phase I trial of glioblastoma therapy
Polyrizon finalises five site agreements for Nasarix trial
The changing landscape of childhood infectious disease in the US
AC Immune’s anti-inflammatory drug posts early-stage win
Reforms to UK clinical trial sector showing signs of success
UK MHRA grants approval for Scancell’s Phase III study of iSCIB1+
Novo Nordisk commences study for reduced Wegovy pill dosing
MSD and Moderna eye cancer vaccine market debut on Phase III melanoma score
Amylyx’s $35m-acquired PBH drug meets endpoints in Phase III trial
Everything on this page was read from markup Salong Debbarma published — a rel="me" link, an h-card, or the feed’s own author element. Nothing was inferred from anywhere else. To correct or remove it, get in touch. Machine-readable: JSON